Increasing Dok-7 Protein Levels May Improve ALS Patients’ Muscle Function, Study Reports
Increasing the production of the muscle protein Dok-7 may be a way to treat the muscle weakness in ALS, a…
Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Increasing the production of the muscle protein Dok-7 may be a way to treat the muscle weakness in ALS, a…
Flex Pharma is launching the Phase 2 COMMEND trial, which will investigate the effects of FLX-787 in patients with muscle…
Scientists have known for some time that abnormal DNA repetitions in the C9orf72 gene contribute to neuron death in ALS…
Researchers have discovered a natural mechanism that can help prevent the formation of harmful protein clumps that contribute to the…
Massachusetts General Hospital in Boston and California Pacific Medical Center in San Francisco will be among the sites where ALS…
A musical instrument that can be played only with brain activity may empower and rehabilitate patients with ALS and other motor…
Neuraltus Pharmaceuticals has completed enrollment its Phase 2 confirmatory study of NP001 (NCT02794857) in ALS patients with systemic…
A moderate to severe traumatic brain injury puts a person at high risk of developing dementia, although not Parkinson’s or ALS,…
Several metals may be linked to the risk of amyotrophic lateral sclerosis (ALS), according to results of a small study…
The former malaria therapy pyrimethamine reduces levels of an ALS-linked protein in the spinal fluid of patients whose disease stems…